RAILY AESMED (02135) issues profit alert, expecting a mid-term profit attributable to shareholders of approximately 4 million yuan, a turnaround from losses to profits year-on-year.

RAILY AESMED (02135) announced that the Group expects to record revenue of approximately RMB 115 million for the six months ending June 30, 2026, compared to approximately RMB 85 million for the six months ending June 30, 2025; and the Group anticipates a profit attributable to the shareholders of the parent company of approximately RMB 4 million for the six months ending June 30, 2026, whereas it recorded a loss attributable to the shareholders of the parent company of approximately RMB 8 million for the six months ending June 30, 2025. The Board believes that the anticipated turnaround from loss to profit for the six months ending June 30, 2026, is primarily due to the growth in revenue during the period, which has led to an increase in gross profit of approximately RMB 15 million. This growth is mainly driven by (i) an increase in revenue from medical beauty services; and (ii) an increase in sales of medical beauty device products.